Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research GlobeNewswire - Fri May 29, 6:30AM CDT

SEATTLE, May 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences GlobeNewswire - Thu May 21, 3:17PM CDT

SEATTLE, May 21, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies: Q1 Earnings Snapshot AP - Tue May 5, 4:01PM CDT

Adaptive Biotechnologies: Q1 Earnings Snapshot

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results GlobeNewswire - Tue May 5, 3:05PM CDT

SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics...

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies Reports Tomorrow With MRD Segment Under Microscope Barchart - Mon May 4, 4:01PM CDT

Barchart Research What to Expect from ADPT Earnings ADPT Generated May 4, 2026 Current Price $14.50 EPS Estimate $$-0.16 Consensus Rating Strong Buy Average Move 8.43% Adaptive Biotechnologies Reports...

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 GlobeNewswire - Wed Apr 15, 3:05PM CDT

SEATTLE, April 15, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies: Q4 Earnings Snapshot AP - Thu Feb 5, 3:53PM CST

Adaptive Biotechnologies: Q4 Earnings Snapshot

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire - Thu Feb 5, 3:05PM CST

SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics...

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences GlobeNewswire - Tue Jan 27, 3:05PM CST

SEATTLE, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 15.15 (-0.26%)
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 GlobeNewswire - Thu Jan 22, 3:05PM CST

SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system...

ADPT : 15.15 (-0.26%)

Barchart Exclusives

Barclays Says Sandisk’s New AI Contracts Could Change the Memory Industry Barchart - Sun May 31, 2:00PM CDT
Sandisk stock is surging after Barclays highlighted the company’s aggressive long-term AI memory contracts and structurally stronger earnings outlook. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.